Histone methyltransferase MLL4 controls myofiber identity and muscle performance through MEF2 interaction
Lin Liu,Chenyun Ding,Tingting Fu,Zhenhua Feng,Ji-Eun Lee,Liwei Xiao,Zhisheng Xu,Yujing Yin,Qiqi Guo,Zongchao Sun,Wanping Sun,Yan Mao,Likun Yang,Zheng Zhou,Danxia Zhou,Leilei Xu,Zezhang Zhu,Yong Qiu,Kai Ge,Zhenji Gan
DOI: https://doi.org/10.1172/jci136155
IF: 19.456
2020-08-04
Journal of Clinical Investigation
Abstract:Skeletal muscle depends on the precise orchestration of contractile and metabolic gene expression programs to direct fiber-type specification and to ensure muscle performance. Exactly how such fiber type–specific patterns of gene expression are established and maintained remains unclear, however. Here, we demonstrate that histone monomethyl transferase MLL4 (KMT2D), an enhancer regulator enriched in slow myofibers, plays a critical role in controlling muscle fiber identity as well as muscle performance. Skeletal muscle–specific ablation of MLL4 in mice resulted in downregulation of the slow oxidative myofiber gene program, decreased numbers of type I myofibers, and diminished mitochondrial respiration, which caused reductions in muscle fatty acid utilization and endurance capacity during exercise. Genome-wide ChIP-Seq and mRNA-Seq analyses revealed that MLL4 directly binds to enhancers and functions as a coactivator of the myocyte enhancer factor 2 (MEF2) to activate transcription of slow oxidative myofiber genes. Importantly, we also found that the MLL4 regulatory circuit is associated with muscle fiber–type remodeling in humans. Thus, our results uncover a pivotal role for MLL4 in specifying structural and metabolic identities of myofibers that govern muscle performance. These findings provide therapeutic opportunities for enhancing muscle fitness to combat a variety of metabolic and muscular diseases.
medicine, research & experimental